Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cenix BioScience GmbH

www.cenix-bioscience.com

Latest From Cenix BioScience GmbH

Silicos NV

Silicos NV's computational lead identification and development platform combines proprietary and commercial computational chemistry tools, and has potential in many indications such as cancer and infectious diseases, central nervous system disorders, and immunodeficiency diseases. The company is using its virtual fragment-based tools to create small molecules for both clients and for its own internal projects.
BioPharmaceutical

Recent Dealmaking (02/2004)

Summarizing the month in European dealmaking.

Cenix BioScience GmbH

Cenix is equipped to do high-throughput, genome-scale RNAi screening. The firm believes that its infrastructure and expertise will allow it to help Big pharma and biotech partners sort through masses of targets to find those with biological relevance. Management believes its methodology can also contribute to drug development--RNAi could, for instance, act as a modifier in screening assays, to see whether this additional means of silencing a gene could improve a drug candidate's activity.
BioPharmaceutical Strategy

Start-Up Previews (12/03)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, Therapeutic Antibodies, features profiles of Acceptys Inc., KaloBios Inc. and Rinat Neuroscience Corp. Plus these Start-Ups Across Health Care: Atritech Inc, AusAm Biotechnologies Inc., Cenix BioScience GMBH and TransOral Pharmaceuticals Inc.
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Infectious & Viral Diseases
  • Inflammation
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • Cenix BioScience GmbH
  • Senior Management
  • Christophe J Echeverri, PhD, CEO & CSO
    Zisi Fotev, PhD, CBO
    Norbert Wilhelms, Head, Fin.
  • Contact Info
  • Cenix BioScience GmbH
    Phone: (49) 351 4173 0
    Tatzberg 47
    Dresden, D-01307
    Germany
UsernamePublicRestriction

Register